Nigella Sativa for Selected Outcomes in Chronic Rhinosinusitis
Status:
Enrolling by invitation
Trial end date:
2023-02-07
Target enrollment:
Participant gender:
Summary
the study is intended to test the effect of Nigella sativa nasal oil drops on selected
outcomes among patients with chronic rhinosinusitis using prospective clinical trial design.
To achieve the aim of the current trial the following research hypotheses are postulated: H1.
The total severity of symptoms mean scores of patients with CRS who will use Nigella sativa
nasal oil drops will be different from the total severity of symptoms mean scores of a
control group.
H2. The total sleep quality mean scores of patients with CRS who will use Nigella sativa
nasal oil drops will be different from the total sleep quality mean scores of a control
group.
H3. The total patient satisfaction mean scores of patients with CRS who will use Nigella
sativa nasal oil drops will be different from the total patient satisfaction mean scores of a
control group.